New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
New Delhi [India], December 25 (ANI): Prime Minister Narendra Modi on Saturday said that the nasal vaccine and the world's first DNA vaccine against the COVID-19 will soon be available for the inoculation drive.
Connecticut [US], December 11 (ANI): In a new study by Yale's Akiko Iwasaki, the Waldemar Von Zedtwitz Professor of Immunobiology, it was found that intranasal vaccination provided broad-based protection against heterologous respiratory viruses in mice.
Moscow [Russia], November 22 (ANI/Sputnik): Russian President Vladimir Putin has offered to become a volunteer in the testing of the Russian candidate nasal vaccine against COVID-19 during a meeting with Denis Logunov, deputy head of the Gamaleya Center, on Sunday.
New Delhi [India], September 8 (ANI): The All India Institute Of Medical Sciences (AIIMS) here will be starting Phase 2/3 trials of Hyderabad-based COVID-19 vaccine manufacturer Bharat Biotech's nasal vaccine soon, sources informed on Wednesday.
New Delhi [India], January 19 (ANI): The Central government on Tuesday said that a nasal vaccine candidate against COVID-19 has been identified that could be a game-changer.
New Delhi [India], January 8 (ANI): The Bharat Biotech International Limited has sent a proposal to the Drugs Controller General of India (DCGI) for conducting the phase 1 trials of a nasal vaccine against COVID-19, informed a government official on Friday.
Washington [US], August 22 (ANI): Scientists have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus. The investigators next plan to test the vaccine in nonhuman pr